Asgari R, Caceres-Valdiviezo M, Wu S, Hamel L, Humber BE, Agarwal SM, et al
Post-marketing surveillance data from regulatory authorities, including the MHRA's Yellow Card scheme, have similarly not identified a clear signal suggesting increased thyroid cancer risk in the general population using these medications
Furthermore, the reduction in adipose tissue mass likely reduced obesity-associated systemic inflammation by reducing the release of pro-inflammatory adipokines, which can drive cartilage degeneration [80] and abnormal subchondral bone remodelling [81]
If youre curious about what peptide therapy might look like for your situation, the best first step is a conversation with a knowledgeable clinician
Please confirm that you are not a robot We're sorry, but it looks like requests sent from your device are automated